fda ruling semaglutide π¨ Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Federal judge upholds FDA's removal
Description
& Giussani, D

WEGOVY injection significantly reduced the risk for first occurrence of MACE

Endocrinology 156: 837846

This strategy ensures the patient remains engaged with the practice throughout their entire weight loss journey, rather than just for a single transaction
The findings have not been replicated in robust controlled studies

The platform has gained attention in the weight-management space, with reports suggesting it serves thousands of patients seeking remote access to semaglutide and tirzepatide
